Further development of refined assays that establish patterns of IFN-γ responses among Mtb-exposed individuals and that distinguish individuals with persistent infection from those who have eliminated Mtb will significantly advance TB-control efforts and targeted preventive therapy programs in resource limiting settings. The gene discussed is IFNG; the disease is tuberculosis.